These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 8940)

  • 1. [Resistance to levomycetin and activity of several enzymes in Escherichia coli and the agent of plague].
    Korobeĭnik NV; Lebedeva SA; Domaradskiĭ IV
    Zh Mikrobiol Epidemiol Immunobiol; 1976; (3):45-50. PubMed ID: 8940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study of the mechanisms of levomycetin inactivation by the palgue causative agent and Escherichia coli with episomal and chromosomal resistance. The enzymatic acetylation of levomycetin].
    Korobeĭnik NV; Lebedeva SA; Mishan'kin BN; Abramova LA; Domaradskiĭ IV
    Antibiotiki; 1975 Sep; (9):817-23. PubMed ID: 1101811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A missense mutation causes aspartase deficiency in Yersinia pestis.
    Viola RE; Yerman L; Fowler JM; Arvidson CG; Brubaker RR
    Microbiology (Reading); 2008 May; 154(Pt 5):1271-1280. PubMed ID: 18451035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consequences of aspartase deficiency in Yersinia pestis.
    Dreyfus LA; Brubaker RR
    J Bacteriol; 1978 Nov; 136(2):757-64. PubMed ID: 711677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Enzymatic inactivation of levomycetin and penicillin by cells of the plague and pseudotuberculosis microbes that contain R plasmid depending on cultivation conditions].
    Korobeĭnik NV; Mishan'kin BN; Lebedeva SA; Abramova LA
    Antibiotiki; 1978 May; 23(5):413-9. PubMed ID: 350142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure of thermostable aspartase from Bacillus sp. YM55-1: structure-based exploration of functional sites in the aspartase family.
    Fujii T; Sakai H; Kawata Y; Hata Y
    J Mol Biol; 2003 May; 328(3):635-54. PubMed ID: 12706722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysogenic conversion of Pasteurella by Escherichia coli bacteriophage P1 CM.
    Lawton WD; Molnar DM
    J Virol; 1972 Apr; 9(4):708-9. PubMed ID: 4553681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetate scavenging activity in Escherichia coli: interplay of acetyl-CoA synthetase and the PEP-glyoxylate cycle in chemostat cultures.
    Renilla S; Bernal V; Fuhrer T; Castaño-Cerezo S; Pastor JM; Iborra JL; Sauer U; Cánovas M
    Appl Microbiol Biotechnol; 2012 Mar; 93(5):2109-24. PubMed ID: 21881893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The highly similar TMP kinases of Yersinia pestis and Escherichia coli differ markedly in their AZTMP phosphorylating activity.
    Chenal-Francisque V; Tourneux L; Carniel E; Christova P; Li de la Sierra I; Bârzu O; Gilles AM
    Eur J Biochem; 1999 Oct; 265(1):112-9. PubMed ID: 10491164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterizing the effect of expression of an acetyl-CoA synthetase insensitive to acetylation on co-utilization of glucose and acetate in batch and continuous cultures of E. coli W.
    Novak K; Flöckner L; Erian AM; Freitag P; Herwig C; Pflügl S
    Microb Cell Fact; 2018 Jul; 17(1):109. PubMed ID: 29986728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of the aspartase activity and its stability in Escherichia coli cells immobilized on polyacrylamide gel and carrageenan].
    Zueva NN; Iakovleva VI; Verevkin AN; Avsiuk IV; Aren AK
    Prikl Biokhim Mikrobiol; 1985; 21(3):334-41. PubMed ID: 3900976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspartase-hyperproducing mutants of Escherichia coli B.
    Nishimura N; Kisumi M
    Appl Environ Microbiol; 1984 Dec; 48(6):1072-5. PubMed ID: 6393873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmid-mediated doxycycline resistance in a Yersinia pestis strain isolated from a rat.
    Cabanel N; Bouchier C; Rajerison M; Carniel E
    Int J Antimicrob Agents; 2018 Feb; 51(2):249-254. PubMed ID: 29030266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MarA-like regulator of multidrug resistance in Yersinia pestis.
    Udani RA; Levy SB
    Antimicrob Agents Chemother; 2006 Sep; 50(9):2971-5. PubMed ID: 16940090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of catalytic activity by gene truncation: activation of L-aspartase from Escherichia coli.
    Jayasekera MM; Saribaş AS; Viola RE
    Biochem Biophys Res Commun; 1997 Sep; 238(2):411-4. PubMed ID: 9299522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microarray expression profiling of Yersinia pestis in response to chloramphenicol.
    Qiu J; Zhou D; Qin L; Han Y; Wang X; DU Z; Song Y; Yang R
    FEMS Microbiol Lett; 2006 Oct; 263(1):26-31. PubMed ID: 16958847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of specific recognition sites of adenine and cytosine DNA-methylase of Yersinia Pestis EV 76 C dam and dcm by Escherichia coli methylases].
    Demidova GV; Goncharov EK; Tynianova VI
    Biokhimiia; 1984 Oct; 49(10):1594-7. PubMed ID: 6097301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elimination of the sensitivity of L-aspartase to active-site-directed inactivation without alteration of catalytic activity.
    Giorgianni F; Beranová S; Wesdemiotis C; Viola RE
    Biochemistry; 1995 Mar; 34(11):3529-35. PubMed ID: 7893648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chromosomal resistance of plague agent to quinolones].
    Kasatkina IV; Shcherbaniuk AI; Makarovskaia LN; Padeĭskaia EN
    Antibiot Khimioter; 1991 Aug; 36(8):35-7. PubMed ID: 1661573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of composition and ionic strength of external solution on the aspartate-ammonia lyase and fumarate hydratase activity in Escherichia coli cells].
    Verevkin AN; Iakovleva VI; Zueva NN
    Biokhimiia; 1989 Dec; 54(12):1994-9. PubMed ID: 2699255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.